Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

SRTA stock hub

Strata Critical Medical, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SRTAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

482M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SRTA

In the news

Latest news · SRTA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E10.3

P25 14.9P50 23.2P75 38.5

ROE-6.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-2.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SRTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001779128
Company name	Strata Critical Medical, Inc.
Country	United States
Country code	US
Employees	327
Employees Change	17%
Employees Change Percent	5.48
Enterprise value	$427.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Isin	US0926671043
Last refreshed	2026-05-10
Market cap	$482M
Market cap category	Small-Cap
Price	$5.57
Price currency	USD
Rev Per Employee	699,012.23x
Sector	Healthcare
Sic	8000
Symbol	SRTA
Website	https://www.stratacritical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.75%
EV Earnings	9.1x
EV Sales Forward	1.56x
EV/Sales	1.87x
FCF yield	-11.82%
P/B ratio	1.69x
P/E ratio	10.26x
P/S ratio	2.11x
PS Forward	1.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.87%
EBITDA Margin	-0.26%
Gross margin	21.08%
Gross Profit	$48.2M
Gross Profit Growth	81.83%
Gross Profit Growth Q	100.16%
Gross Profit Growth3 Y	22.03%
Gross Profit Growth5 Y	54.34%
Net Income	$47M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-7.02%
Profit Margin	20.56%
Profit Per Employee	$143,713
Profitable Years	1
ROA	-1.91
ROCE	-2.88
ROE	-6.35
ROIC	-2.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	101.18%
Cagr3y	28.25%
Cagr5y	-8.53%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	74.15x
Revenue Growth Q	87.45x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	11.53x
Revenue Growth5 Y	51.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.79
Assets	$327.6M
Cash	$58.8M
Current Assets	$124.1M
Current Liabilities	$20.9M
Debt	$4.5M
Debt EBITDA	$5.47
Debt Equity	$0.02
Equity	$285.7M
Liabilities	$41.9M
Long Term Assets	$203.5M
Long Term Liabilities	$20.9M
Net Cash	$54.3M
Net Cash By Market Cap	$11.27
Net Cash Growth	-51.03%
Net Debt Equity	$-0.19
Tangible Book Value	$150.8M
Tangible Book Value Per Share	$1.74
WACC	15.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.93
Net Working Capital	$45.4M
Quick ratio	4.7
Working Capital	$103.2M
Working Capital Turnover	$1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.82%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	101.08%
200-day SMA	4.72
3Y total return	110.99%
50-day SMA	4.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-35.98%
All Time High	19.88
All Time High Change	-71.98%
All Time High Date	2021-02-16
All Time Low	2.06
All Time Low Change	170.39%
All Time Low Date	2023-10-30
ATR	0.29
Beta	2.15
Beta1y	2.46
Beta2y	2.01
Ch YTD	15.8
High	5.6
High52	6.02
High52 Date	2025-09-19
High52ch	-7.48%
Low	5.3
Low52	2.84
Low52 Date	2025-05-08
Low52ch	96.13%
Ma50ch	21.99%
Premarket Change Percent	0
Premarket Price	$5.34
Premarket Volume	13,181
Price vs 200-day SMA	18.08%
RSI	69.92
RSI Monthly	59.98
RSI Weekly	61.68
Sharpe ratio	1.31x
Sortino ratio	2.42
Total Return	-7.82%
Tr YTD	15.8
Tr1m	37.19%
Tr1w	9.65%
Tr3m	17.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	63,720,000x
Earnings Revenue Estimate Growth	17.34x
Operating Income	$-8.8M
Operating margin	-3.87
Price target	$7.81
Price Target Change	$40.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61,751,931%
Float Percent	71.37%
Shares Insiders	13.69%
Shares Institutions	52.87%
Shares Out	86,526,570
Shares Qo Q	6.46%
Shares Yo Y	7.82%
Short Float	9.57%
Short Ratio	8.81
Short Shares	6.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-75.6M
Average Volume	807,326.45x
Bv Per Share	3.3
CAPEX	$-12.2M
Ch1m	37.19
Ch1w	9.65
Ch1y	101.1
Ch3m	17.51
Ch3y	111
Ch5y	-35.98
Ch6m	25.73
Change	4.31%
Change From Open	4.5
Close	5.34
Days Gap	-0.19
Depreciation Amortization	8,263,000
Dollar Volume	4,585,981.5
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-8.8M
EBITDA	$-583,000
EPS	$0.56
F Score	3
FCF	$-56.9M
FCF EV Yield	-13.32x
FCF Per Share	$-0.66
Financing CF	-5,525,000
Fiscal Year End	December
Founded	2,014
Goodwill	88,589,000
Graham Number	6.46867
Graham Upside	16.13
Investing CF	74,072,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	4.79
Ma150ch	16.26%
Ma20	4.85
Ma20ch	14.85%
Net CF	23,299,000
Next Earnings Date	2026-08-15
Open	5.33
Optionable	Yes
Position In Range	90
Post Close	5.57
Postmarket Change Percent	-0.36
Postmarket Price	$5.55
Ppne	44,282,000
Pre Close	5.34
Price Date	2026-05-08
Ptbv Ratio	3.2
Relative Volume	1.02x
Revenue	228,577,000x
SBC By Revenue	8.16x
Share Based Comp	18,650,000
Tr6m	25.73%
Us State	New York
Volume	823,336
Z Score	5.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SRTA pay a dividend?

Capital-return profile for this ticker.

Performance

SRTA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SRTA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+52.9%

Float: +71.4% of shares outstanding

Insider ownership

+13.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SRTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.9

Neutral momentum band

Price vs 200-day MA

+18.1%

50/200-day relationship not available

Beta (5Y)

2.15

More volatile than the market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SRTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SRTA stock rating?

Strata Critical Medical, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SRTA analysis?

The full report lives at /stocks/SRTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SRTA?

The latest report frames SRTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SRTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.